VALEANT PHARMACEUTICALS INTL's ticker is and the CUSIP is 91911K902. A total of 11 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $244,000 | -17.0% | 17,000 | 0.0% | 0.27% | -18.3% |
| Q2 2017 | $294,000 | +56.4% | 17,000 | 0.0% | 0.33% | +45.2% |
| Q1 2017 | $188,000 | -23.9% | 17,000 | 0.0% | 0.23% | -29.4% |
| Q4 2016 | $247,000 | -40.8% | 17,000 | 0.0% | 0.33% | -40.9% |
| Q3 2016 | $417,000 | +21.9% | 17,000 | 0.0% | 0.55% | +3.6% |
| Q2 2016 | $342,000 | -23.5% | 17,000 | 0.0% | 0.53% | -15.8% |
| Q1 2016 | $447,000 | -79.9% | 17,000 | +70.0% | 0.63% | -63.1% |
| Q2 2015 | $2,222,000 | +11.9% | 10,000 | 0.0% | 1.71% | +9.4% |
| Q1 2015 | $1,986,000 | +38.8% | 10,000 | 0.0% | 1.57% | +54.7% |
| Q4 2014 | $1,431,000 | +9.1% | 10,000 | 0.0% | 1.01% | +14.9% |
| Q3 2014 | $1,312,000 | – | 10,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|